WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc. is a biotechnology research and development company operating within the healthcare sector, primarily focused on the discovery and development of therapies for cancer and diseases of the central nervous system. The company's notable expertise lies in researching medicinal products based on biological compounds and small molecules, with a distinct emphasis on targeted therapies for brain gliomas and other oncology indications. While WPD Pharmaceuticals once held active business operations, its current structure centers around possessing a minority equity stake—approximately 7%—in its former Polish subsidiary, which continues to specialize in oncology-focused biotechnological research and development. This remaining asset positions WPD Pharmaceuticals as a holder of interests in innovative oncology research, reflecting the company's ongoing connection to the advancement of novel therapeutic solutions for challenging medical conditions in the biotechnology industry.